Condition
severe asthma without chronic rhinosinusitis
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Tezepelumab
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Not Yet Recruiting1
Clinical Trials (1)
Research Network
Common Treatments
- Tezepelumab1
Active Sponsors
- Medical University of Vienna1
Top Investigators
Medical University of Vienna
Related Conditions
- Chronic Rhinosinusitis With Nasal Polyps Crswnp1
- Asthma Bronchiale1
- Severe Asthma And Chronic Rhinosinusitis With Nasal Polyps1